The capacity of a combined liposomal hepatitis B and C vaccine to stimulate humoral and cellular responses in mice

Viral Immunology

Volumn 11, Issue 2, 1998, Pages 73-78

  Khemka, Vimla ^a   See, Darryl ^a   See, Jackie ^a   Chang, Jennifer ^a   Chou, Shioweh ^a   Tilles, Jeremiah ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; HEPATITIS C ANTIGEN; HEPATITIS C VACCINE; LIPOSOME;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; ENCAPSULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FREEZE DRYING; HUMORAL IMMUNITY; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; SEROCONVERSION; SPLEEN CELL;

ANIMALIA; HEPATITIS B VIRUS; HEPATITIS C VIRUS;

EID: 0031692243     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.1998.11.73     Document Type: Article

References (14)

1. Advisory Committee for Immunization Practices. 1991. Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. MMWR 40 (PR-13):1-25.
2. Alving, C.R., 1991. Liposomes as carriers of antigens and adjuvants: J. Immunol. Methods 140:1-13.
3. Bangham, A. 1968. Membrane models with phospholipids. Prog. Biophys. Mol. Biol. 18:29-36.
4. Bergers, J.J., T.L.M. ten Hagen, W.E.M. van Etten, and I. Bakker-Woudenberg. 1995. Liposomes as delivery systems in the prevention and treatment of infectious diseases. Pharm. World Sci. 17(1):1-11.
5. Choo Q, G. Kuo, R. Ralston, A. Weiner, D. Chien, G. Van Nest, J. Han, K. Bergeer, K. Thudium, C. Kuo, J. Kansopon, J. McFarland, A. Tabrizi, K. Ching, B. Moss, L. Cummins, M. Houghton, and E. Muchmore. 1994. Vaccination of chimpanzees against infection by the hepatitis C virus. Proc. Natl. Acad. Sci. USA 91: 1294-1298.
6. Haq, T.A., H.S. Masson, J.D. Clements, and C.J. Arntzen. 1995. Oral immunization with a recombinant bacterial antigen produced in transgenic plants. Science 268:714-716.
7. Kane, M. 1995. Global programme for control of hepatitis B infection Vaccine 13 (Suppl. 1):547-549.
8. Lemon, S., and E. Brown. 1995. In G. Mandell, R. Douglas, and J. Bennett, (eds): Principles and Practice of Infectious Diseases, 4th ed. Churchill Livingstone, New York.
9. Petruff, C.A., A. Bedford, F.D. Gordon, and S. Chopra. 1997. Hepatitis vaccine. Dig. Dis. 15:1-22.
10. Prezzi, C., M. Nuzzo, A. Meola, P. Delmastro, G. Galfre, R. Cortese, A. Nicosia, and P. Monaci. 1996. Selection of antigenic and immunogenic mimics of hepatitis C virus using sera from patients. J. Immunol. 156:4504-4513.
11. See D., J. See, T. Clark, and J. Tilles. 1997. Successful immunization of mice using liposomes containing inactivated, prototype strains of all six types of coxsackievirus group B viruses. Vaccine Research 6:27-32.
12. Singh, M., X.M. Li, J.P. McGee, T. Zamb, W. Koff, C.Y. Wang, and D.T. O'Hagan. 1997. Controlled release microparticles as a single dose hepatitis B vaccine; evaluation of immunogenicity in mice. Vaccine 15:475-481.
13. Sugarman, S., and R. Perex-Soler. 1992. Liposomes in the treatment of malignancy: a clinical perspective. Crit. Rev. Oncol. Hematol. 12:231-242.
14. Swensen, C.E., M.C. Popsecu, and R.S. Ginsberg. 1988. Preparation and use of liposomes in the treatment of microbial infections. Crit. Rev. Microbiol. 15 (Suppl. 1): 1-31.